AGIO

#1989
Agios Pharmaceuticals, Inc.
33.2700 USD
+0.36%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
33.0800
33.4200
Intervallo Annuale
22.2400
45.9900
Variazione giornaliera
+0.36%
Variazione Mensile
+20.06%
Variazione di 6 mesi
-23.32%
Variazione Annuale
-23.32%
Chiusura Precedente
33.1500
Apertura
33.1200
Bid
Ask
Minimo
33.0800
High
33.4200
Volume
472
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 1.9494 B
  • Employee 540
  • Founded 2008
  • CEO N/A
  • Website www.agios.com
  • Headquarter Delaware, United States
  • FIGI BBG000QY4ZD0
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.82
Rapporto prezzo/fatturato
29.21

Agios Pharmaceuticals Inc

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

Notizie